Tandem Diabetes Care International

Optimise diabetes care for pediatric patients with Control-IQ technology — see it live at ISPAD! 🎤 Industry Session: Every Day, Every Stage: Using Control-IQ Technology to Meet the Unique Needs of Pediatric Patients📅 Friday, 7 Nov | 🕑 8-9 am | 📍 Hall 3 💡 Visit booth #1 to explore our latest innovations for pediatric patients, talk to our experts, and see live product demos. 📍 We’ll be there from 8 am–6 pm. 📅 5-8 November Don’t miss it! ℹ️ http://spklr.io/6043BzGER #ISPAD2025 #DiabetesAwareness #DiabetesTechnology #TandemDiabetes #tslimX2 Safety info: http://spklr.io/6044BzGEr

👋Bonjour from the 51st Annual Meeting of ISPAD in Montreal, Canada! Explore Tandem insulin pumps with Control-IQ technology — designed to help improve outcomes with ease for younger patients. 📱 Learn how the Tandem Source platform and Tandem t:slim mobile app work together to simplify diabetes management, from data review to daily use. Let’s talk innovation, share insights, and shape the future of diabetes care — come meet our team! Visit our booth #1 from 8 am-6 pm 📅 5-8 November ℹ️ http://spklr.io/6045BzGDL #ISPAD2025 #DiabetesAwareness #DiabetesTechnology #TandemDiabetes #tslimX2 Safety info: http://spklr.io/6046BzGD0

We can’t wait till the 51st Annual Conference of the International Society for Pediatric and Adolescent Diabetes (ISPAD) in Montreal, Canada next week. Join us for our Industry Session: Every Day, Every Stage: Using Control-IQ Technology to Meet the Unique Needs of Pediatric Patients. Discover how to optimize outcomes across the treatment journey of young patients using Control-IQ technology. 📅 Friday, 7 November🕖 8-9 am📍 Hall 3 Visit us at booth #1 to: - Learn about our latest innovations for pediatric patients - Connect with experts ready to answer your questions - Experience live demos of our products We look forward to welcoming you between 8 am–6 pm 📅 5-8 November See you in Montreal! ℹ️ http://spklr.io/6040BzGDY #ISPAD2025 #DiabetesAwareness #DiabetesTechnology #TandemDiabetes #tslimX2 Safety info: http://spklr.io/6041BzGDl

🔍 New study alert: Automated insulin delivery (AID) systems help lower healthcare utilisation and costs While the clinical benefits of automated insulin delivery (AID) systems for people with type 1 diabetes (T1D) are well-established, payers and healthcare systems are increasingly focused on the long-term impact on healthcare resource utilisation and costs. A new retrospective analysis — the first integrated, real-world study of its kind — examines how AID technology compares with multiple daily injection (MDI) therapy in terms of acute healthcare utilisation. This study included 7264 AID system users and 27,973 MDI users. 📊 Key findings: ✅ Individuals using AID experienced fewer emergency department visits and fewer hospital admissions than those on MDI therapy ✅ Overall inpatient care costs were lower among AID users ✅ These results indicate that broader adoption of AID systems may lead to better clinical outcomes and reduced healthcare expenditure This growing body of real-world evidence supports the clinical and economic value of AID technology in diabetes care. Read the full study here 👉 http://spklr.io/6044BzGDK Manjelievskaia J, et al. Diabet Med. 2025;00:e70147. doi: 10.1111/dme.70147. Safety info: http://spklr.io/6045BzGDz

👏 Join our webinar for healthcare professionals and discover Tandem Source—the new platform designed to make diabetes treatment and management easier, more efficient, and seamlessly integrated into your workflow. 📣 Topic: Making Easy Treatment Adjustments with Tandem Source (15 October) - 12:00-1:00 PM CET, register here: https://shorturl.at/3hbUC - 7:00-8:00 PM CET, register here: https://shorturl.at/CjQq7 You’ll learn practical ways to use Tandem Source in daily patient care, including tips on treatment adjustments for the t:slim insulin pump with Control-IQ technology to help optimize outcomes. Each topic is offered twice (midday and evening) so you can choose the time that works best for you. This webinar is intended for HCPs only. Safety info: https://lnkd.in/d3SmUSb

👏 Join our webinar series for healthcare professionals and discover Tandem Source—the new platform designed to make diabetes treatment and management easier, more efficient, and seamlessly integrated into your workflow. You’ll learn practical ways to use Tandem Source in daily patient care, including tips on treatment adjustments for the t:slim insulin pump with Control-IQ technology to help optimize outcomes. Each topic is offered twice (midday and evening) so you can choose the time that works best for you. 📣 Topic 1: Introducing Tandem Source (Tuesday, 7 October) - 12:00-1:00 PM CET, register here: https://shorturl.at/hgfkj - 7:00-8:00 PM CET, register here: https://shorturl.at/XHtzo 📣 Topic 2: Making Easy Treatment Adjustments with Tandem Source (15 October)  - 12:00-1:00 PM CET, register here: https://shorturl.at/3hbUC - 7:00-8:00 PM CET, register here: https://shorturl.at/CjQq7 This webinar is intended for HCPs only. Safety info: https://lnkd.in/d3SmUSb

✨ What an incredible few days at EASD! Thank you to everyone who visited our booth or joined the symposium — it was wonderful connecting with you! We’re excited to share that the Tandem Source platform and Tandem t:slim X2 mobile app are now launching in more markets, bringing greater simplicity to diabetes management for both users and healthcare professionals. At our symposium, ‘Easy Steps With Control-IQ Technology: From Day 1 to Daily Life,’ our wonderful speaker, Dr. Laurel Messer, VP of Medical Affairs, demonstrated how Control-IQ technology supports optimized outcomes across the treatment journey, making diabetes management easier and more effective from the very start. Let’s keep the conversations going — we look forward to exchange more insights soon!! #EASD2025 #DiabetesAwareness #DiabetesTechnology #TandemDiabetes #tslimX2 Safety info: https://lnkd.in/d3SmUSb

Introducing Tandem Source: The go-to platform for everything Tandem for healthcare professionals and Tandem insulin pump users. We’re excited to launch Tandem Source in Czech Republic, Switzerland, Spain, Portugal, and Italy. What is Tandem Source? One platform for both healthcare professionals and Tandem pump users, designed with real customer feedback to simplify data review and pump software updates. - Web-based platform — no software installation needed - Free of cost for both users and healthcare professionals - Easy-to-read, adjustable reports — three consolidated reports featuring key data and customizable views for timeframe and target glucose ranges to support impactful therapy adjustments - Web-based updater — easier, faster pump updates directly in Tandem Source, with fewer steps and no extra software downloads* We’re excited to bring this seamless experience to more countries soon. #DiabetesAwareness #DiabetesTechnology #TandemDiabetes #tslimX2 * Future updates for all or some Tandem products may not be developed and may not be offered everywhere and would be subject to applicable regulatory approvals. Software updates are only available to customers who are in warranty at the time they update their pump. Additional training may be required to access certain software updates. Charges may apply. Tandem may discontinue select software and features over time at its discretion. This product may not be right for you. Always read and follow the label. Indicated for patients with type 1 diabetes, 6 years and older. BOXED WARNING: Control-IQ technology should not be used by people under age 6, or who use less than 10 units of insulin/day, or who weigh less than 25 kilograms. Safety info: http://spklr.io/6049BJDe7